The CD4 + and CD8 + T cell dichotomy is essential for effective cellular immunity. How individual T cell identity is established remains poorly understood. Here we show that the high-mobility group (HMG) transcription factors Tcf1 and Lef1 are essential for repressing CD4 + lineage-associated genes including Cd4, Foxp3 and Rorc in CD8 + T cells. Tcf1-and Lef1-deficient CD8 + T cells exhibit histone hyperacetylation, which can be ascribed to intrinsic histone deacetylase (HDAC) activity in Tcf1 and Lef1. Mutation of five conserved amino acids in the Tcf1 HDAC domain diminishes HDAC activity and the ability to suppress CD4 + lineage genes in CD8 + T cells. These findings reveal that sequence-specific transcription factors can utilize intrinsic HDAC activity to guard cell identity by repressing lineage-inappropriate genes.
Cell identity is established by lineage-determining transcription factors, which initiate and sustain expression of cell-type-specific genes while repressing those in alternative lineages [1] [2] [3] [4] . Important insights and extrapolatable paradigms have been derived from hematopoietic cells. Transcription factors have instructive roles in precursor cells for lineage determination; for example, GATA-1 and PU.1 antagonistically control development of erythroid-megakaryocytes and myeloid cells, respectively 5, 6 . Lineage-committed cells remain dependent on key transcription factors to guard cell identity. Deletion of Pax5 in mature B cells causes de-differentiation to uncommitted progenitors, which generate T lineage cells 7 . Loss of Bcl11b induces T cells to acquire properties of natural killer cells 8 . During and after establishment of cell identity, transcription factors are assisted by epigenetic mechanisms-i.e., covalent modification of DNA and/or nucleosomal histones-to ensure heritable expression of lineageappropriate genes 2, 4 .
CD4 + and CD8 + T cells are functionally distinct lymphocytes that have essential roles in immune defense against foreign pathogens and transformed cells. Whereas CD8 + T cells are dedicated cytotoxic cells, CD4 + T cells provide help tailored to specific pathogen types. In spite of the functional disparity, naive CD4 + and CD8 + T cells have remarkably similar transcriptomes, with few genes exhibiting lineage-restricted expression 9 . Among the CD4 + signature genes, Zbtb7b (here called Thpok), encoding transcription factor ThPOK, protects CD4 + lineage integrity in mice 10 . Naive CD4 + T cells lacking ThPOK show high expression of CD8 coreceptors, the transcription factor Runx3 and strong upregulation of cytotoxicity-associated genes 10 . HDAC1 and HDAC2, although not exclusively expressed in CD4 + T cells, have a similar protective effect on CD4 + lineage integrity. Deletion of HDAC1 and HDAC2 in CD4 + T cells in mice causes induction of a CD8 + effector-like program 11 . In contrast, it remains unknown how CD8 + T cell identity is regulated.
Tcf1 and Lef1 (encoded by Tcf7 and Lef1, respectively) are HMG transcription factors that are required for early stages of thymocyte maturation [12] [13] [14] [15] . Induction of Tcf1 in early thymic progenitors by Notch signaling is essential for T cell lineage specification 16, 17 . In T lineage-committed thymocytes, Tcf1 prevents malignant transformation and promotes β-selection at the CD4 − CD8 − doublenegative-3 (DN3) stage 18, 19 . Upon maturation of DN thymocytes to the CD4 + CD8 + double-positive (DP) stage, DP cells face a lineage 'choice' of becoming either CD4 + or CD8 + T cells 20 . In DP thymocytes, Tcf1 and Lef1 act upstream of ThPOK and regulate CD4 + lineage decision 13, 21 . Therefore, Tcf1 and Lef1 have versatile, developmental-stage-specific roles during T cell maturation.
Here we report that Tcf1 and Lef1, although not required for DP thymocytes to choose the CD8 + fate, are essential for establishing CD8 + T cell identity, and this function is mediated by HDAC activity intrinsic to these two factors. Our data suggest that Tcf1 and Lef1 directly bridge genetic and epigenetic regulation to establish a gene-expression pattern appropriate for CD8 + lineage T cells. 6 9 6 VOLUME 17 NUMBER 6 JUNE 2016 nature immunology A r t i c l e s RESULTS Ablating Tcf1 and Lef1 induces CD4 + genes in CD8 + T cells Tcf1 and Lef1 are required for the CD4 + lineage 'decision' 21 . Mice with CD4-Cre-mediated deletion of loxP-flanked Tcf7 and Lef1 (CD4-Cre + Tcf7 FL/FL Lef1 FL/FL , called Tcf7 −/− Lef1 −/− mice hereafter) had fewer CD4 + mature thymocytes but a higher proportion of CD8 + mature thymocytes than wild-type (WT) mice 21 (Supplementary Fig. 1a ). Tcf7 −/− Lef1 −/− CD8 + T cells retained CD8 + T cell features such as production of interferon-γ and perforin 21 and expression of a CD8 + cell-specific transcript of Runx3 (Runx3d) as well as Nkg7 and Itgae (Supplementary Fig. 1b ), but they aberrantly expressed the CD4 coreceptor 21 (Supplementary Fig. 1a) . To assess the global impact of Tcf1 and Lef1 deficiency, we performed RNA-seq analysis on sortpurified CD69 − CD24 − TCRβ + CD8 + mature thymocytes from Tcf7 −/− , Tcf7 −/− Lef1 −/− and control littermates (CD4-Cre + Tcf7 +/+ Lef1 +/+ , CD4-Cre + Tcf7 FL/+ Lef1 FL/+ or CD4-Cre − mice). We found that 718 genes were downregulated and 472 genes were upregulated in Tcf7 −/− Lef1 −/− compared to control CD8 + mature thymocytes at a setting of ≥2-fold expression changes and false discovery rate (FDR) < 0.01 ( Fig. 1a) . Among the genes markedly upregulated in Tcf7 −/− Lef1 −/− CD8 + thymocytes were those encoding CD8 + T cell effector molecules such as Blimp1 (Prdm1), perforin (Prf1) and Fas ligand (Fasl) ( Supplementary  Fig. 1c ). Tcf7 −/− Lef1 −/− CD8 + T cells were neither aberrantly activated (as determined by the CD44 hi CD62L lo phenotype) nor enriched for IL-2Rβ + CD44 hi memory-phenotype T cells ( Supplementary Fig. 1a,d) .
We also surveyed the V β TCR repertoire in CD8 + mature thymocytes in Tcf7 −/− Lef1 −/− and control littermates and found that no particular V β subtype was over-represented owing to Tcf1 and Lef1 deficiency ( Supplementary Fig. 1e,f) . Thus, the global transcriptomic changes in Tcf7 −/− Lef1 −/− CD8 + T cells were not associated with abnormal expansion of a specific TCR chain or functional T cell subset. Our data suggest that Tcf1 and Lef1 restrain effector molecule expression in naive CD8 + T cells to prevent aberrant cytotoxic activities.
Tcf7 −/− Lef1 −/− CD8 + mature thymocytes also showed increased expression of genes related to the CD4 + lineage, including Cd4 and Foxp3, Gata3 and Rorc (Fig. 1b) . Using published data 9 , we constructed a CD4 + T cell gene set that contained 108 genes expressed ≥2-fold in CD4 + over CD8 + T cells ( Supplementary Table 1 ). Gene set enrichment analysis (GSEA) revealed that 37 genes in the CD4 + T cell gene set showed enriched expression in Tcf7 −/− Lef1 −/− compared to control CD8 + thymocytes, including all five CD4 + T cell signature genes (Cd4, Thpok, St8sia6, Lgmn and Cd40lg) that are not expressed in naive CD8 + T cells (Fig. 1c) . The increased expression of CD4 + lineage-associated genes in Tcf7 −/− Lef1 −/− CD8 + thymocytes was validated with qRT-PCR (for Cd40lg, St8sia6a, Lgmn, Itgb3 and Gata3) or intracellular staining of Foxp3 and Rorγt proteins ( Supplementary  Fig. 2a,b) . Among the CD8 + T cell effector molecules, increased protein expression of Fas ligand (FasL) was evident in naive Tcf7 −/− Lef1 −/− splenic CD8 + T cells, and elevated expression of CD40L and granzyme B was detected in Tcf7 −/− Lef1 −/− splenic CD8 + T cells only after in vitro priming ( Supplementary Fig. 2c-e ).
Because CD4 + T cells are redirected to CD8 + lineage upon loss of Tcf1 and Lef1 (ref. 21) , the increased expression of CD4 + lineage-associated genes in Tcf7 −/− Lef1 −/− CD8 + T cells might be derived from their origin as CD4 + T cells. To address this possibility, we crossed Tcf7 −/− Lef1 −/− mice to H2ab1 −/− mice, which are deficient in major histocompatibility complex class II (MHC-II-deficient), to minimize CD4 + T cell production and, hence, their redirection to CD8 + lineage. Compared to CD8 + mature thymocytes in H2ab1 −/− mice, Tcf7 −/− Lef1 −/− H2ab1 −/− CD8 + thymocytes showed high expression of Cd40lg, St8sia6 and Lgmn and of CD4, Foxp3 and Rorγt proteins ( Fig. 1d,e ), independent of lineage redirection. We also noted that the upregulation of CD4, Foxp3 and Rorγt proteins occurred in only a fraction of Tcf7 −/− Lef1 −/− CD8 + thymocytes, in both the MHC-II-sufficient and MHC-II-deficient backgrounds ( Fig. 1e and Supplementary Fig. 2b) , indicative of variegated gene expression. 
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These data indicate that Tcf1 and Lef1 are intrinsically required for maintaining the CD8 + T lineage integrity.
Histone hyperacetylation in Tcf1-Lef1-deficient CD8 + T cells Variegated gene expression, i.e., conversion between silenced and expressed status in a proportion of given cell population, is suggestive of epigenetic regulation 22 . Cd4 gene silencing in CD8 + T cells is known to be mediated by epigenetic mechanisms 23 . To investigate how Tcf1 and Lef1 deficiency affects the epigenome of CD8 + T cells, we used chromatin immunoprecipitation coupled with high-throughput sequencing (ChIP-seq) analysis of histone H3 trimethylation at K4 or K27 (H3K4me3 or H3K27me3) or acetylation at K9 or K27 (H3K9Ac or H3K27Ac) in WT and Tcf7 −/− Lef1 −/− CD8 + mature thymocytes and WT CD4 + mature thymocytes. The loci of 108 genes in CD4 + T cell gene set had stronger H3K4me3 signals in WT CD4 + than WT CD8 + thymocytes, and there was a moderate increase in both H3K4me3 and H3K27me3 signals at these loci in Tcf7 −/− Lef1 −/− compared to WT CD8 + thymocytes ( Supplementary Fig. 3a ). However, the CD4 + T cell gene set showed substantially stronger H3K27Ac signals in both WT CD4 + and Tcf7 −/− Lef1 −/− CD8 + thymocytes than in WT CD8 + thymocytes ( Fig. 2a) . We observed a similar but less pronounced trend for H3K9Ac ( Fig. 2a) . For individual CD4 + T cell signature genes, we found strong H3K27Ac signals in both WT CD4 + and Tcf7 −/− Lef1 −/− CD8 + thymocytes at the transcription start sites (TSSs) and intron regions of Cd4, St8sia6 and Itgb3, and at the Cd40lg upstream and Lgmn downstream regulatory regions ( Fig. 2b and Supplementary Fig. 3b ).
We next analyzed histone modifications of all the 472 genes upregulated in Tcf7 −/− Lef1 −/− CD8 + mature thymocytes. In addition to their high H3K4me3 signals, these loci showed markedly higher H3K27Ac and H3K9Ac signals in Tcf7 −/− Lef1 −/− than in WT CD8 + thymocytes ( Fig. 2c and Supplementary Fig. 3c ). Tcf7 −/− Lef1 −/− CD8 + thymocytes showed increased H3K27Ac compared with WT CD8 + thymocytes at the Foxp3 upstream regulatory region and Rorc gene body (Supplementary Fig. 3d ) and at the TSSs of Prdm1 and Fasl (Fig. 2d) . Mature thymocytes and peripheral T cells have nearly identical transcriptomes 9 , suggesting that transcriptional and epigenetic regulation is preserved in mature T cells during egress from the thymus to peripheral lymphoid tissues. Using ChIP-qPCR, we validated increased H3K27Ac in Tcf7 −/− Lef1 −/− compared to WT splenic CD8 + T cells at the Cd4 TSS and silencer, the TSSs or upstream regulatory regions of other CD4 + signature genes (St8sia6, Cd40lg and Itgb3) and the TSSs of CD8 + T cell effector genes such as Prdm1 and Fasl ( Fig. 2e) . In contrast, an increase in H3K4me3 and/or a decrease in H3K27me3 were observed only at the TSSs of St8sia6 and Fasl in Tcf7 −/− Lef1 −/− CD8 + T cells ( Supplementary Fig. 4 ). Tcf1 and Lef1 deficiency thus led to increases in H3K27Ac and H3K9Ac marks in CD8 + T cells at lineage-inappropriate gene loci, which may account for their aberrant upregulation.
For the overall histone modification status, H3K27Ac and H3K9Ac signals were substantially elevated in Tcf7 −/− Lef1 −/− compared to control splenic CD8 + T cells, whereas the amounts of H3K4me3 and H3K27me3 were similar ( Fig. 3a) . Reanalysis of the RNA-seq data comparing Tcf7 −/− Lef1 −/− and control mature CD8 + thymocytes did not npg A r t i c l e s identify major gene-expression changes in known HDACs or histone acetyltransferases due to Tcf1 and Lef1 deficiency ( Supplementary  Fig. 5 ). Next we performed Tcf1 ChIP-seq using WT or Tcf7 −/− splenic CD8 + T cells and a protocol in which sonication intensity and duration were reduced to better preserve protein complexes bound to chromatin. Using a stringent fourfold enrichment threshold (P < 10 −5 and FDR < 0.05 setting), we identified 7,807 high-confidence Tcf1 binding peaks (more than that identified in published studies) 21 . Both H3K27Ac and H3K9Ac signals were relatively weak at the Tcf1 binding sites in WT CD8 + mature thymocytes but were substantially elevated in Tcf7 −/− Lef1 −/− CD8 + mature thymocytes ( Fig. 3b) .
Among the 472 genes upregulated in Tcf7 −/− Lef1 −/− CD8 + thymocytes, 202 genes harbored Tcf1 binding peaks within the −5 kb to +5 kb genomic regions flanking the gene loci ( Table 1 ). In addition to Cd4 (ref. 21) , Tcf1 bound to several other CD4 + lineage-associated genes (Itgb3, St8sia6 and Cd40lg) and CD8 + T cell effector genes (Prdm1 and Fasl) ( Fig. 2b,d and Supplementary Fig. 3b ). Among the 202 Tcf1-bound genes, more than 80% showed increased H3K27Ac and about one-third showed increased H3K9Ac signals in Tcf7 −/− Lef1 −/− compared to control CD8 + thymocytes ( Table 1 ). The same trend was observed when the search of Tcf1 peaks was expanded to the −50 kb to +50 kb regulatory regions flanking the gene loci, revealing that Tcf1 was associated with Foxp3 and additional sites in the Fasl gene ( Fig. 2d and Supplementary Fig. 3d ). These observations suggest that Tcf1 and Lef1 restrain histone acetylation in the CD8 + T cell genome at their occupancy sites and directly associated genes.
Tcf1 has intrinsic HDAC activity
We next investigated whether Tcf1 and Lef1 have intrinsic HDAC activity. We employed proteins translated in vitro (IVT proteins) in HDAC assays using a fluorogenic substrate, Boc-Lys(Ac)-AMC. IVT HDAC1 showed dose-dependent deacetylation of the substrate, as expected. IVT full-length Tcf1 (p45 Tcf1, 45-kDa) showed HDAC activity, but IVT Runx3 did not ( Fig. 4a) . HDACs are divided into four classes on the basis of phylogenetic analysis and sequence homology 24 . The sirtuin family (including SIRTs 1-7) constitutes class III; the classical HDACs fall into classes I (HDACs 1, 2, 3 and 8), II and VI (HDAC11). Class II HDACs contains class IIa (HDACs 4, 5, 7 and 9) and class IIb (HDACs 6 and 10). We found that the HDAC activities of both HDAC1 and Tcf1 were potently inhibited by the pan-HDAC inhibitor vorinostat and were unaffected by sirtinol, a sirtuin-specific inhibitor ( Fig. 4b) . Trichostatin A (TSA) and MS-275, selective inhibitors of class I HDACs 25 , strongly inhibited HDAC1 but not Tcf1 HDAC activity (Fig. 4b) . Tubacin, a selective HDAC6 inhibitor, greatly diminished Tcf1 HDAC activity but only weakly affected HDAC1 (Fig. 4b) . We also purified His-tagged Tcf1 recombinant protein and confirmed dose-dependent HDAC activity in Tcf1 (Fig. 4c) . Recombinant Tcf1 was sensitive to vorinostat and tubacin but less responsive to TSA or sirtinol ( Fig. 4d) . These data indicate that Tcf1 has intrinsic HDAC activity.
Mapping of the HDAC activity domain in Tcf1
Tcf1 is expressed in multiple isoforms in T cells. Unlike p45 Tcf1, the p33 Tcf1 isoform lacks the N-terminal β-catenin-interacting domain. Both isoforms have the same C-terminal HMG DNAbinding domain. A series of C-terminal truncation mutants of p45 Tcf1 that partially or completely lacked the HMG domain as well as p33 Tcf1 maintained HDAC activity ( Fig. 5a-c) . The HDAC domain is thus located between residues 116 and 235 in Tcf1 and is independent of the β-catenin-interacting and HMG domains. We then made internal deletions within this 120-aa region ( Fig. 5d,e ). Deletion of residues 192-206 (loop 3) or 207-221 (loop 4) greatly reduced Tcf1 HDAC activity, and combined deletion of both segments (loop 34) further abolished Tcf1 HDAC activity ( Fig. 5f) . Thus, a 30-aa domain (Q192-L221) in Tcf1 is essential for its HDAC activity.
Tcf1 catalyzes deacetylation of histone substrates
To further analyze the intrinsic HDAC activity of Tcf1, we employed gel filtration-fast protein liquid chromatography (FPLC) to enhance the purity of recombinant Tcf1 protein ( Supplementary Fig. 6a,b ) and used the FPLC-purified Tcf1 in two newly developed HDAC assays. First, we used H3K9Ac or H3K27Ac proteins as substrates. Similar to a commercially available HDAC1, FPLC-purified Tcf1 caused deacetylation of both H3K9Ac and H3K27Ac (Fig. 6a) . In contrast, the loop 34 Tcf1 mutant had no detectable impact on the acetylation status of H3K9Ac and H3K27Ac substrates, similar to glutathione S-transferase (GST) purified from the same host bacteria ( Fig. 6a) .
Second, we used a segment (residues 1-21) of H3 protein acetylated at K9 (H3(1-21)K9Ac peptide) as a substrate to determine the kinetic parameters of Tcf1 catalytic activity. Both H3(1-21)K9Ac peptide and its deacetylated form were readily detected on matrix-assisted laser desorption and ionization mass spectrometry (MALDI-MS), with distinct molecular mass ( Supplementary Fig. 6c ). Like HDAC1, FPLC-purified Tcf1 effectively converted the H3(1-21)K9Ac peptide to its deacetylated form ( Fig. 6b) , the identity of which we confirmed by laser-induced fragmentation time-of-flight (LIFT) MS ( Supplementary Fig. 6d ). The loop 34 Tcf1 mutant did not catalyze deacetylation of H3(1-21)K9Ac peptide, similarly to GST (negative control) ( Fig. 6b) . FPLC-purified Tcf1 showed dose-dependent deacetylation of the H3(1-21)K9Ac peptide ( Fig. 6c) . By varying the substrate concentrations, we estimated the V max for Tcf1-catalyzed H3(1-21)K9Ac deacetylation to be 0.71 × 10 −6 mM/s, with a K m of 0.022 mM ( Fig. 6d and Supplementary Fig. 6e ). These assays with highly purified Tcf1 protein and physiological substrates further establish the intrinsic HDAC activity in Tcf1.
Structural similarity between Tcf1 and conventional HDACs
To gain structural insights into Tcf1 HDAC activity, we used SWISS-MODEL 26 Fig. 7a) . In particular, the 30-aa Tcf1 HDAC domain was predicted to form an α-helix with an extended loop and bore strong resemblance to the corresponding region (G271-L299) in HDAC8 (Fig. 7a) . The HDAC8 G271-L299 region constitutes an important component in its catalytic pocket 29 . By extension, we posit that the 30-aa Tcf1 HDAC domain contributes to forming an activity center that catalyzes histone deacetylation.
To further pinpoint the key residues responsible for the Tcf1 HDAC activity, we constructed multiple sequence alignments comparing HDAC domains in Tcf1 and conventional HDACs based on structural homology, global and local sequence comparisons. The alignments revealed that 11 amino acids in the 30-aa Tcf1 HDAC domain were conserved to various degrees with the HDAC domains in class I, IIa and IIb HDACs (Fig. 7b) . Several of these critical residues were also conserved between Tcf1 and Lef1 (Fig. 7c) , and mutating five of these conserved amino npg A r t i c l e s acids (Mut5aa) in Tcf1 diminished its HDAC activity (Fig. 7c,d) . IVT Lef1 protein also showed similar HDAC activity to that of Tcf1, and the Mut5aa mutation in Lef1 impaired its HDAC activity as well ( Fig. 7c,d) . Besides the few conserved residues, the overall sequence conservation between Tcf1 and Lef1 was not high in the putative HDAC domains. Direct-coupling analysis (DCA) is a powerful tool to identify residue pairs in protein domains that may have coevolved to preserve physical proximity in the 3D conformation of the domain 30 . DCA on 98 unique primary sequences of Tcf1 and Lef1 orthologs retrieved from 56 species identified several residue pairs that probably coevolved within their HDAC domains (Supplementary Fig. 7) . These coevolving pairs in Tcf1 and Lef1 suggest that a similar functional structure in the HDAC domains may have been preserved in spite of their sequence divergence. These structure-function analyses further corroborate the idea that Tcf1 and Lef1 have intrinsic HDAC activity.
Tcf1 HDAC activity is essential for CD8 + lineage integrity To further substantiate a requirement for the intrinsic HDAC activity of Tcf1 in vivo, we used retroviruses expressing GFP and WT p45 Tcf1 or Tcf1 Mut5aa to infect lineage-negative bone marrow (BM) cells from CD45.2 + Tcf7 −/− Lef1 −/− mice, which were then transplanted into WT CD45.1 + congenic recipients ( Supplementary  Fig. 8a) . The Tcf1 Mut5aa mutant was chosen over larger internal deletions to minimize potential impact on protein structure in vivo. Donor-derived CD45.2 + GFP + T cells were analyzed in the BM chimeras 6 weeks after transplantation. Both WT p45 Tcf1 and Tcf1 Mut5aa preserved similar DNA-binding capacity, as assessed by electrophoretic mobility-shift assay ( Supplementary  Fig. 8b) , and the ability to bind known Tcf1 target genes such as Lef1 and Axin2 in vivo, as assessed by ChIP ( Supplementary  Fig. 8c ). Retroviral WT p45 Tcf1 and Tcf1 Mut5aa were detected at similar levels in the retrovirally transduced Tcf7 −/− Lef1 −/− CD8 + T cells (Supplementary Fig. 8d ). Numbers of CD4 + T cells are greatly diminished in Tcf7 −/− Lef1 −/− mice 21 , and this phenotype persisted in Tcf7 −/− Lef1 −/− BM chimeras transduced with empty vector (Fig. 8a) . Retroviral expression of WT p45 Tcf1 or Tcf1 Mut5aa showed similar capacities to increase CD4 + T cell frequency and numbers in the BM chimeras but only modestly increased CD8 + T cell output ( Fig. 8a and Supplementary Fig. 8e-f ). qRT-PCR analysis of emptyvector-transduced Tcf7 −/− Lef1 −/− CD8 + T cells showed derepression of CD4 + lineage-associated genes such as St8sia6, Cd40lg and Itgb3 and upregulation of CD8 + T cell effector genes Prdm1, Prf1 and Fasl; in contrast, forced expression of WT p45 Tcf1 substantially repressed the expression of these genes (Fig. 8b) . In addition, retroviral WT p45 Tcf1 expression decreased the percentages of CD4 + or Foxp3 + Tcf7 −/− Lef1 −/− CD8 + T cells and repressed FasL protein expression in Tcf7 −/− Lef1 −/− CD8 + T cells ( Supplementary Fig. 8g-i) .
In contrast, these 'rescue' effects by WT p45 Tcf1 were not evident in Tcf1-Mut5aa-transduced Tcf7 −/− Lef1 −/− CD8 + T cells ( Fig. 8b and Supplementary Fig. 8g-i) , highlighting an essential requirement for Tcf1 HDAC activity in suppressing lineage-inappropriate genes in CD8 + T cells. In addition, Tcf7 −/− Lef1 −/− CD8 + T cells transduced with WT p45 Tcf1 showed much lower amounts of total H3K27Ac than Tcf7 −/− Lef1 −/− CD8 + T cells transduced with empty vector, whereas cells transduced with Tcf1 Mut5aa did not (Fig. 8c) . Furthermore, retroviral WT p45 Tcf1, but not the Mut5aa form, diminished H3K27Ac signal at the Cd4, St8sia6, Cd40lg, Prdm1 and Fasl gene loci, which showed elevated H3K27Ac in emptyvector-transduced Tcf7 −/− Lef1 −/− CD8 + T cells (Fig. 8d) . These in vivo data indicate that Tcf1 controls histone acetylation to establish an epigenetic landscape suitable for CD8 + T cell identity.
DISCUSSION
Establishing and maintaining the CD4 + and CD8 + T cell dichotomy is essential for effective cellular immunity. ThPOK, HDAC1 and HDAC2 are known to maintain the integrity of CD4 + T cells by repressing CD8 + lineage-associated genes 10, 11 . Here we find Tcf1 and Lef1 transcription factors have a reciprocal role, i.e., they establish CD8 + T cell identity by repressing the CD4 + T cell program. This critical function is mediated by HDAC activity intrinsic to Tcf1 and Lef1. Histone deacetylation is an evolutionarily conserved means of gene repression 31 . Until now, HDAC activity has been thought to be limited to dedicated proteins, including HDACs 1-11 and SIRTs 1-7 (ref. 24 ). HDAC proteins regulate key functions in T cells 32 , such as HDAC1 and HDAC2 in the DN-to-DP transition 33 , HDAC6 in T cell migration 34 and HDAC7 in TCR signaling 35 . The intrinsic HDAC activity of Tcf1 and Lef1 adds them to the HDAC family. Notably, although several HDAC or SIRT proteins are expressed in T lineage cells, they cannot compensate for the loss of Tcf1 and Lef1 in regulating histone deacetylation in CD8 + T cells. This consideration highlights the uniqueness of HDAC activity in Tcf1 and Lef1 and/or the requirements for proper positioning of HDAC activity at target gene loci.
We found that Tcf1 HDAC activity is sensitive to some HDAC inhibitors, suggesting at least partial structural similarity between the HDAC domain of Tcf1 and that of conventional HDACs. Homology modeling predicted that the Tcf1 HDAC domain would adopt a similar structure to a region in HDAC8 catalytic pocket. The 271G-299L region in HDAC8, which corresponds to the Tcf1 30-aa HDAC domain, constitutes only a portion of the HDAC8 catalytic pocket 29 . This suggests that the Tcf1 HDAC domain and possibly neighboring residues may fold to form a catalytic center that has features distinct from conventional HDACs. Partial crystal structures of Tcf and Lef family members have been reported, including the β-catenin-binding domain in XTcf3 (ref. 36 ) and the HMG domain of Lef1 (ref. 37) . Solving the structure of the whole Tcf1 protein or its HDAC domain will provide definitive insights into the molecular basis underlying its intrinsic HDAC activity. npg A r t i c l e s The dual capacity of direct DNA binding and intrinsic HDAC activity in Tcf1 and Lef1 confers unique advantages to these factors in gene regulation. Tcf1-occupied sites in the CD8 + T cell genome were associated with hyperacetylation of H3K27 and H3K9 upon loss of Tcf1 and Lef1. In contrast, among the 472 genes upregulated in Tcf7 −/− Lef1 −/− CD8 + T cells, not all harbor Tcf1 binding sites in the vicinity of these gene loci. One possible explanation is that HDAC activity of Tcf1 and Lef1, like the conventional HDACs, is recruited to gene loci by other DNA-binding transcription factors. Indeed, direct interaction between Tcf1 or Lef1 and the transcription factors Foxp3, GATA3 and Runx has been previously documented 21, 38, 39 . Histone acetylation is a dynamic process; half-lives of histone acetyl groups are on the order of minutes 40 . Constant addition and removal of acetyl groups to histones may require a dynamic interaction of Tcf1 or Lef1 with the histone substrates that may not be readily captured by ChIPseq. We postulate that the histone deacetylation capacity of Tcf1 and Lef1 may not necessarily depend on their direct contact with DNA and may be utilized in versatile ways.
Tcf1 binds to the well-characterized Cd4 silencer in the first intron of the Cd4 gene, and Tcf1 directly interacts with Runx3 to synergistically suppress Cd4 transcription in CD8 + T cells 21 . In addition to transcriptional repression, HDAC activity in Tcf1 and Lef1, brought to the locus by direct binding or recruitment by Runx3, has important contributions to Cd4 gene silencing, as evidenced by increased H3K27Ac at the Cd4 silencer in Tcf7 −/− Lef1 −/− compared to WT CD8 + T cells. Beyond Cd4 gene silencing, we found that Tcf1 and Lef1 have broad roles in repressing the expression of CD4 + T lineageassociated genes and CD8 + T cell effector genes, and this function of gene repression requires their intrinsic HDAC activity. Tcf-and Lef-mediated gene repression is thought to depend on interaction with known transducin-like enhancer (TLE) corepressors 14 . Our findings suggest that the HDAC activity of Tcf1 and Lef1 may be synergistic with TLE recruitment or 'divide labor' with TLE proteins to achieve global and site-specific suppression of gene expression in a given cell type.
A prevailing view in epigenetic regulation is that the machinery for histone modification must be recruited to the target gene loci through sequence-specific transcription factors. The identification of intrinsic HDAC activity in transcription factors thus reveals a flexible regulatory capacity that directly bridges genetic and epigenetic regulation of gene expression. The expanded regulatory capacity of transcription factors may be broadly used in cell development, function and transformation.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Gene Expression Omnibus: RNA-seq and ChIP-seq data have been deposited under accession number GSE73240.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METHODS
Animals. Tcf7 fl/fl and Lef1 fl/fl mice were described 18, 21 . B6.SJL mice were from the Jackson Laboratory. H2ab1 −/− mice were from Taconic. All mouse experiments were performed under protocols approved by the Institutional Animal Use and Care Committee of the University of Iowa. Mice of both sexes were analyzed at 6-15 weeks of age. No randomization was used, and no blinding was done.
Flow cytometry and cell sorting. Single cell suspensions from the mouse thymus and spleen were prepared as described 18, 21 . The cells were surfacestained with various combinations of the following antibodies: anti-CD4 (M1/69), anti-CD8α (53-6.7), anti-TCRβ (H57-597), anti-CD69 (H1.2F3), anti-CD44 (IM7), anti-CD24 (M1/69), anti-CD62L (MEL-14), anti-CD40L (MR1) and CD45.2 (104) (all from eBiosciences). Anti-IL-2Rβ (TM-β1) and anti-FasL (MFL3) were from BD Biosciences. Anti-granzyme B (GB/2) was from Thermo Fisher Scientific. The Vβ TCR Screening Panel (BD Biosciences) was used to survey the Vβ TCR repertoire. For intranuclear staining, the surface-stained cells were fixed and permeabilized with Foxp3/Transcription Factor Staining Buffer Set (eBiosciences) and stained with anti-Foxp3 (eBiosciences, FJK-16s), anti-Rorγt (eBiosciences, B2D), or anti-Tcf1 (C63D9, Cell Signaling Technologies). The stained cells were analyzed on FACSVerse (BD Biosciences). All antibodies were used at dilutions of 1:50 to 1:100 and validated for mouse and flow cytometry as indicated by the data sheets from the manufacturers. The data were processed using FlowJo software (Version X, TreeStar). For cell sorting, surface-stained thymocytes or splenocytes were sorted on FACSAria (BD Biosciences) from Tcf7 −/− Lef1 −/− or control mice for RNA-seq analysis and gene-expression validation.
Reverse transcription and qPCR. Total RNA from the sorted cells was extracted and reverse-transcribed using QuantiTech Reverse Transcription Kit (Qiagen). The resulting cDNA was analyzed for expression of different genes using SYBR Advantage qPCR Premix (Clontech) on an ABI 7300 Real Time PCR System (Applied Biosystems). The primers are listed in Supplementary  Table 2 . The relative expression of a gene of interest was determined by normalizing to Hprt in each sample.
RNA-seq and data processing. CD8 + thymocytes were sorted from the TCRβ hi CD24 − CD69 − mature thymocyte population in Tcf7 −/− , Tcf7 −/− Lef1 −/− or control mice, and total RNA was extracted as described 18 . cDNA synthesis and amplification were performed using SMARTer Ultra Low Input RNA Kit (Clontech) starting with 10-100 ng of total RNA per sample according to the manufacturer's instructions. cDNA was fragmented with Q800R sonicator (Qsonica) and used as input for NEBNext Ultra DNA Library Preparation Kit (NEB). Libraries were sequenced on Illumina's HiSeq2000 in single-read mode with the read length of 50 nt, producing 60-70 million reads per sample. Sequence data in FASTQ format were generated with the CASAVA 1.8.2 processing pipeline from Illumina.
The sequencing quality of RNA-seq libraries was assessed by FastQC v0.10.1 (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The RNA-seq libraries were then processed by RSEM (v1.2.21) 41 to estimate expression levels of all genes. The expression of a gene is represented by a gene-level value of fragments per kilobase of transcripts per million mapped reads (FPKM). The reproducibility of RNA-seq data was evaluated by computing Pearson's correlation of FPKM values for all genes between biological replicates. The Pearson's correlation coefficient between the two biological replicates was 0.999 for both control and Tcf7 −/− samples, and 0.996 for the Tcf7 −/− Lef1 −/− samples, indicating strong reproducibility. EBSeq (v1.5.4), an integral component of the RSEM package, was used to identify differentially expressed genes 42 . Upregulated or downregulated genes in Tcf7 −/− Lef1 −/− CD8 + T cells were identified by requiring ≥2-fold expression changes and false discovery rate (FDR) < 0.01, as well as FPKM ≥ 1 in Tcf7 −/− Lef1 −/− CD8 + T cells, for upregulated genes, or FPKM ≥ 1 in control CD8 + T cells, for downregulated genes. UCSC genes from the iGenome mouse mm9 assembly (http://support.illumina.com/sequencing/sequencing_ software/igenome.html) were used for gene annotation.
ChIP and qPCR. WT CD4 + or CD8 + and Tcf7 −/− Lef1 −/− CD8 + mature thymocytes or splenic CD8 + T cells were sorted and crosslinked with 1% formaldehyde in medium for 5 min, processed using truChIP Chromatin Shearing Reagent Kit (Covaris), and sonicated for 5 min on Covaris S2 ultrasonicator. The resulting sheared chromatin fragments were 200-500 bp and were immunoprecipitated with antibodies to H3K4me3 (Millipore, 17-614), H3K9Ac (Abcam, ab4441), H3K27me3 (Millipore, 17-622), H3K27Ac (Abcam, ab4729), or control IgG and washed as described 18 . For calculation of histone mark signals in a given cell type in ChIP-PCR experiments, each histone mark ChIP sample was normalized to corresponding IgG ChIP sample for a target region. In genetic complementation experiments, the H3K27Ac signal was normalized to input DNA from the same sample. The PCR primers for the target regions are listed in Supplementary Table 2 .
For Tcf1 ChIP, WT or Tcf7 −/− splenic CD8 + T cells were sorted and crosslinked for 10 min. The cells were suspended in a nuclear lysis buffer containing 50 mM Tris-HCl (pH 8.1), 10 mM EDTA, 0.1% SDS and 1× protease inhibitor cocktail (Sigma-Aldrich), and sonicated with a Q125 sonicator equipped with an 1/8-inch diameter probe (QSonica) at 20% input amplitude, 20 s, eight times. The resulted chromatin fragments were 300-1,500 bp in size and were immunoprecipitated with an anti-Tcf1 serum 43 and washed as described 18 . The immunoprecipitated DNA fragments were used for library construction or PCR quantification.
ChIP-seq and data processing. DNA segments from ChIP were end-repaired and ligated to indexed Illumina adaptors followed by low-cycle PCR. The resulting libraries were sequenced with the Illumina HiSeq-2000 platform. The sequencing quality of ChIP-seq libraries was assessed by FastQC. Ends of sequencing reads were trimmed according to the sequencing quality. Bowtie2 v2.2.5 (ref. 44 ) was used to align the sequencing reads to the mouse genome. UCSC genes from the iGenome mouse mm9 assembly were used for gene annotation.
For histone modification ChIP-seq libraries, SICER v1.1 (ref. 45 ) was used to identify ChIP-enriched islands under the setting of false discovery rate (FDR) < 10 −4 . The island-filtered histone mark reads were used for downstream analysis. For Tcf1 ChIP-seq in CD8 + T cells, MACS v1.4.2 (ref. 46) was used for peak calling with Tcf1 ChIP-seq in Tcf7 −/− CD8 + T cells as a negative control. We used a stringent setting, i.e., ≥4-fold enrichment, P < 10 −5 , and FDR < 5%, and identified 7,807 high-confidence Tcf1 binding sites.
Analysis of the distribution of histone marks at specific sets of genomic landmarks.
To analyze the profile of a histone mark around transcription start sites (TSSs) of a particular gene set, the TSSs were first aligned, and the island-filtered reads of the histone mark in nonoverlapping windows of 100 bases were counted within a ±5 kb region flanking all the TSSs of the gene set. The window read counts were then normalized by the number of genes and by the window size per kilobase. The profile was further normalized by the total number of island-filtered reads in the histone mark library as reads per million.
For the aggregated profile of a histone mark flanking the 7,807 highconfidence Tcf1 binding sites, the island-filtered reads were counted both inside and outside all the sites. Inside the Tcf1 binding sites, the reads were counted in windows equal to 5% of the site length. Outside the Tcf1 binding sites, the reads were counted in nonoverlapping windows of 250 bases from −5 kb upstream to the start of Tcf1 sites and from the end of Tcf1 sites to +5 kb downstream. All read counts were normalized by the number of sites and the window size per kilobase. The profile was further normalized by the total number of island-filtered reads in the histone mark library as reads per million.
GSEA.
Microarray data comparing CD4 + and CD8 + SP thymocytes were downloaded from the Immunological Genome Project (http://www.immgen. org) 9 . A total of 108 genes showed ≥2-fold higher expression in CD4 + than in CD8 + T cells and were defined as the CD4 + T cell gene set ( Supplementary  Table 1 ). GSEA software was downloaded from the Broad Institute 47 and used to determine the enrichment of gene sets in Tcf7 −/− Lef1 −/− and control CD8 + mature thymocytes.
Histone purification and immunoblotting. Tcf7 −/− Lef1 −/− or control CD8 + mature thymocytes were sort-purified, and histone protein was extracted npg following a protocol from Abcam. In brief, the cells were washed twice with ice-cold PBS and suspended in Triton Extraction Buffer to isolate the nuclei. The nuclear extracts were resuspended in 0.2 N HCl and incubated overnight to extract histone proteins. The same antibodies for histone marks used in ChIP assays were used for immunoblotting. Total H3 histone was detected with the ab1791 antibody (Abcam).
Generation of Tcf1 mutants and in vitro translation. Flag-tagged Tcf1 and Lef1 were cloned under the T7 promoter in the pBlueScript vector (Agilent Genomics). To generate C-terminus-truncated Tcf1 proteins, a stop codon was inserted into appropriate locations using the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies). To generate internal deletions, the targeted regions were looped out using primers complementary to their flanking sequences. Mutation of the five conserved amino acids in the HDAC domains of Tcf1 and Lef1 was achieved with the same mutagenesis approach using extra-long flanking primers. All mutants were verified to have the desired mutations without irrelevant changes. The pBlueScript constructs expressing WT or mutant p45 Tcf1 and WT or mutant Lef1 were linearized, and corresponding proteins were generated by in vitro translation using the TNT T7 coupled Wheat Germ Extract System (Promega) following the manufacturer's instructions.
Fluorometric deacetylation assay and HDAC inhibitors. The HDAC Activity Fluorometric Assay Kit (BioVision) was used to measure deacetylation activity of in vitro translated or recombinant proteins. The test samples were incubated with the provided fluorogenic substrate, Boc-Lys(Ac)-AMC (Nα-(t-butoxycarbonyl)-Nω-acetyl-l-lysine 7-amido-4-methylcoumarin) in 1× HDAC Assay Buffer at 37 °C for 2.5 h, and then the reaction was stopped by adding the Lysine Developer and further incubated at 37 °C for 30 min. The produced fluorescence was measured in a 96-well black plate (Thermo Scientific) using the Synergy H1 Hybrid reader (BioTek Instruments) with excitation at 360 nm and emission at 460 nm. In some assays, the following HDAC inhibitors were used at concentrations 20-to 300-fold of their reported IC 50 : vorinostat, MS-275 (also known as entinostat), tubacin, sirtinol (all from Cayman Chemical) and trichostatin A (Sigma-Aldrich).
HDAC assay using protein substrates. Recombinant H3K9Ac (catalog number 31253) and H3K27Ac (31290, Active Motif) were used as substrates for HDAC assay. The reaction contained 1× HDAC assay buffer (20 mM Tris-HCl (pH 8.0) and 150 mM NaCl), 0.2 mM ZnCl 2 , 0.2 µg substrate protein, and 2 µg of GST, FPLC-purified WT Tcf1, or Tcf1-loop34 protein.
Recombinant HDAC1 protein (31342, Active Motif) was used at 1 µg in each reaction as a positive control. The reaction was carried out at 25 °C for 12 h and stopped by addition of SDS-PAGE loading buffer followed by treatment at 95 °C for 5 min. The samples were then resolved on a 15% SDS-PAGE gel and subject to immunoblotting with anti-H3K9Ac, H3K27Ac, or total H3 antibody as above.
HDAC assay using a peptide substrate. Histone H3(1-21) peptide (ARTKQTARKSTGGKAPRKQLA, AS-61701) and its K9 acetylated form, H3(1-21)K9Ac (AS-64191) were from AnaSpec. The H3K9Ac peptide was used in place of protein substrate in the HDAC assay described above, except that ZnCl 2 was omitted. The reaction was carried out using varied amounts of FPLC-purified Tcf1 for test of dose dependency, or using varied reaction times and substrate concentrations for kinetic analysis. The reaction was stopped by snap-freeze on dry ice followed by MS analysis.
MALDI-MS.
2 µl of the HDAC reaction containing H3(1-21)K9Ac peptide substrate was mixed thoroughly with 1 µl supernatant from saturated α-cyano-4-hydroxycinnamic acid (CHCA, Sigma-Aldrich) in 50% acetonitrile and 0.2% trifluoroacetic acid (TFA, Sigma-Aldrich) and spotted on to a MTP 384-well Anchor Chip MALDI plate with hydrophilic centers of 0.8 mm (Bruker). Desalting in situ was performed by rinsing each dried spot with 3 µl 0.1% TFA for 20 s.
MALDI-TOF spectra were acquired with a Bruker Ultraflex TOF/TOF mass spectrometer equipped with gridless delayed extraction ion source, frequency-tripled NdYAG laser (50 µJ, 3-ns pulse) using a SmartBeam II controller to distribute power across the pulse, a low-mass ion suppressor, electronic precursor selection, collision cell, LIFT cell for fragment ion post-acceleration, a post-LIFT metastable suppressor and a gridless ion reflector 48 . Mass calibration solutions were prepared from Michrom bovine serum albumin digests (Bruker). Fourteen peptides ranging in m/z from 927.495 (Tyr-Leu-Tyr-Glu-Ile-Ala-Arg) to 2,615.123 (Val-His-Lys-Glu-Cys-Cys-His-Gly-Asp-Leu-Leu-Glu-Cys-Ala-Asp-Asp-Arg-Ala-Asp-Leu-Ala-Lys), with carboxymethylcysteine as a global modification, established a mass accuracy of 4 p.p.m.
Peptide spectra. A gridless ion source floats initially at a homogeneous 25,140 V positive bias. Following each laser pulse, a delay of 90 ns transpires before the bias of the second lens is dropped 22,540 V to extract ions. Ions <800 Da were electronically deflected out of the beam line. Ions traversed an Einsel lens held at 8.2 kV and a two-stage, grid-free reflector with mid-mirror voltage of 13.44 kV and back mirror voltage of 26.66 kV. The SmartBeam II was usually run at 70% attenuation, firing at 200 to 2,000 Hz with a laser spot diameter of 60 µm. The linear and reflector detector biases were set at 2.4 kV and 2.1 kV, respectively. The digitizer is an Acqiris U1084A, v.1.16, with 524-Mb memory, a full-scale sensitivity set to 100 mV and analog offsets set to 50 mV. Mass spectral data were generated by summing 2,000-4,000 laser shots.
For relative quantification of H3 in the K9Ac (substrate) and deacetylated (product) forms, a fresh preparation of saturated MALDI matrix supernatant was mixed with a fixed amount of angiotensin I (m/z 1,296.69 Da) such that 10 fmol was deposited per spot. Mass spectra data for both peptides were obtained in 8-11 replicates. Spectra were accumulated for each spot until the area of angiotensin I isotype pattern reached 5,000 counts. The areas under four consecutive peaks for each peptide (e.g., encompassing the natural abundance of stable isotopes) were calculated in each replicate, and the relative quantity of the deacetylated H3(1-21) product was determined for kinetics analysis.
Laser-induced fragmentation time-of-flight (LIFT). The Ultraflex III also has a selected ion sequencing mode that is enabled when a second ion source is positioned into the beam line. This LIFT cell is situated beyond the collision cell and the Timed Ion Selection (TIS) gates. During LIFT acquisitions, laser power is increased about 40% to increase internal energy of intact peptides which accelerates post-source decay. The bias between the first source and LIFT cell is maintained at only 7.5 kV to improve the precision of TIS precursor isolation. Resolution of the TIS, R = m/∆m, is effectively 1,000, meaning all ions are attenuated before entering the LIFT cell save a bolus of ±1.5 Da centered on the monoisotopic peak of the H3K9Ac peptide or its deacetylated product. In the four-stage LIFT cell the voltage potential is raised from ground to 19 kV, and fragment ions are spatially focused via deceleration and fullbias pulse into the reflector (which itself compensates for energy dispersion). Following the LIFT cell another TIS acts as a metastable deflector for precursor ions. Hence a focused array of fragment ions arrive at the dual microchannel plate which is set off the beam line following the ion reflector. Ion mass is determined by previous calibration of arrival times.
Ladder sequence ions were assigned using BioTools 3.2 SR4 to pass centroid data (SNAP algorithm) to the MASCOT version 2.5. The 8 August 2015 version of the SwissProt database (ftp://ftp.uniprot.org/pub/databases/ uniprot/current_release/) restricted to human taxonomy was searched accepting variable lysine acetylation, excluding all global modifications and specifying no enzyme. MASCOT identified substrate H3K9Ac and deacetylated product peptides with a score of 86 and 84, respectively, with a mass window of 0.1 Da.
Retroviral transduction and generation of BM chimeras. WT p45 Tcf1 or Tcf1
Mut5aa was cloned into the MIG-R1 bicistronic retroviral vector with GFP as an expression indicator. Each retrovirus was packaged by transient transfection of 293T cells with the retroviral vector along with pCL eco using Lipofectamine 2000 (Life Technologies) following the manufacturer's instructions. The retrovirus-containing medium was harvested for infection of BM stem and progenitor cells 49 .
BM cells were isolated from Tcf7 −/− Lef1 −/− mice and depleted of all lineagepositive cells by labeling with biotinylated lineage markers in combination with streptavidin-coupled M280 Dynabeads (Life Technologies). Lin − BM cells were cultured overnight in IMDM medium with 15% FBS, 50 µM 2-mercaptoetha-nol, 100 µg/ml streptomycin and penicillin, 50 ng/ml stem cell factor (SCF), and 20 ng/ml thrombopoietin (TPO) in a 24-well flat-bottom plate at 0.5 × 10 6 per ml. The cells were then resuspended in retrovirus-containing medium with refreshed cytokines, loaded onto non-tissue-culture 24-well plates coated with 10 µg retronectin per well (Takara), and 'spinofected' at 1,000 × g for 90 min at room temperature in the presence of 4 µg/ml Polybrene (hexadimethrine bromide). After spinofection, the cells were cultured with the retroviruscontaining medium for an additional 2 h, and the medium was then replaced with IMDM supplemented with cytokines as above. The spinofection was repeated on the following day, and 24 h later, the infected BM stem or progenitor cells were transplanted into lethally irradiated (1,050 rad) CD45.1 + B6.SJL mice. Six weeks after transplantation, CD8 + T cell lineage integrity was analyzed using the thymuses and spleens from the recipients.
Purification of Tcf1 and other recombinant proteins. Tcf1 cDNA was inserted in-frame with an N-terminal His tag in the pET-28 vector. The plasmid was transformed into Rosetta competent cells (EMD Millipore), and a single clone was cultured in LB medium at 37 °C. When the OD at 595 nm reached 0.6, isopropyl β-d-1-thiogalactopyronaside (IPTG, Thermo-Fisher Scientific) was added to the culture at a final concentration of 0.5 mM, and the culture was continued for additional 10 h at room temperature. The bacterial pellet was washed with cold PBS and lysed in lysis buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.9, 0.2% Triton X-100, 10 mM imidazole, 1 mM PMSF and protease inhibitor cocktail from Sigma-Aldrich) by incubation on ice for 30 min. The lysates were then sonicated using a Q700 sonicator (QSonica) using a 0.25-inch diameter probe at 30% input amplitude, six times. The translucent lysates were centrifuged and the supernatants were incubated with His60 Nickel Superflow Resin (Takara-Clontech) at 4 °C for 4 h. The resin was then collected and washed three times with the lysis buffer before loading onto a Microspin Chromatography Column (Bio-Rad Laboratories). The His-tagged Tcf1 protein was eluted with elution buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.9, 200 mM imidazole, 1 mM PMSF and protease inhibitor cocktail). The eluate fractions with high amounts of His-tagged Tcf1 proteins were collected and dialyzed against PBS, pH 7.4, in Slide-A-Lyzer mini dialysis units (Thermo-Fisher Scientific) for 4 °C for 4 h. Protein purity was verified by SDS-PAGE followed by Coomassie staining, and proper expression of Histagged Tcf1 was confirmed by immunoblotting with anti-Tcf1 (Cell Signaling Technologies, clone C46C7) and anti-His (Cell Signaling Technologies, clone 27E8) antibodies. The protein was quantified and used in the fluorometric deacetylation assay.
HDAC-like activity has been reported in bacteria 50 , and we adopted the following approaches to further eliminate possible contamination by bacterial HDAC or other proteins. The pellet of Rosetta bacteria expressing Tcf1 was lysed in a lysis buffer containing 500 mM NaCl (all other components were as above). The same buffer was used for binding of His-tagged Tcf1 to the Nickel Superflow Resin. This modification allowed dissociation of bacterial DNA from the imidazole-eluted Tcf1 protein. The Tcf1 preparation was then run over a Superdex 75 10/300 GL column (GE Healthcare Life Sciences) using an AKTA-pure FPLC. The running buffer consisted of 50 mM Tris-HCl (pH 8.0) and 500 mM NaCl. The purity of select fractions was assessed by SDS-PAGE followed by Coomassie blue staining or silver staining using Pierce silver stain for mass spectrometry (Pierce). The fractions containing predominantly Tcf1 without apparent other contaminating proteins were dialyzed in 50 mM Tris-HCl (pH 8.0) and 150 mM NaCl, and used in HDAC assays using acetylated H3 proteins or peptide as substrates.
To provide proper negative controls for the HDAC assays, we used either His-tagged recombinant Pfh8 protein (amino acids 539-689) or GST protein isolated from the same host bacteria. To purify GST protein, pGEX4T-1 vector that express the GST tag was transformed into the Rosetta competent cells, cultured as above, and the resulting bacterial pellet was lysed in lysis buffer containing 150 mM NaCl and centrifuged as above. The lysates were incubated with Glutathione Magnetic Beads (Pierce) at 4 °C for 2 h; beads were then collected and washed three times with lysis buffer. GST protein was eluted from the beads using 10 mM reduced glutathione (Research Products International) and dialyzed in 50 mM Tris-HCl (pH 8.0) and 150 mM NaCl.
Electrophoretic mobility shift assay (EMSA). Recombinant WT p45 Tcf1 and its mutants (0.6 µg each) were incubated in an EMSA buffer containing 20 mM KCl, 0.5 mM dithiothreitol, 0.5 mM EDTA, 10% glycerol, and 1 µg polyinosinic:polycytidylic acid (Sigma-Aldrich) on ice for 15 min followed by an additional 15-min incubation with a Tcf-and Lef-binding TOP probe . The TOP oligonucleotides, 5′-GATCTAGGGCACCCTTTGAAGCTCT and 5′-AGAGCTTCAAAGGGTGCCCTAGATC, contain the consensus Tcf-Lef binding motif (underlined), and were synthesized in 5′-biotinylated form and annealed as the probe. In the competition assay, unmodified TOP oligonucleotides were synthesized separately and annealed as the competitor. The protein-DNA complex was resolved on native PAGE containing 6% acrylamide. The DNA was transferred to BrightStar-Plus positively charged nylon membrane (Ambion/Life Technologies) and then UV-crosslinked. The biotinylated probe, free or in the protein complex, was detected with streptavidin-conjugated horseradish peroxidase coupled with chemiluminescent substrate in the LightShift Chemiluminescent EMSA kit (Thermo Fisher Scientific).
Homology modeling. SWISS-MODEL 26 was employed to construct a 3D structure for Tcf1 using homology modeling. The sequence of Tcf1 (UniProt Q00417) was obtained from UniProt 51 . The known HDAC8 crystal structure (PDB 3F0R) was used as the desired template. The structures were visualized using PyMOL (https://www.pymol.org/).
Multiple sequence alignment of Tcf1 and HDACs.
The sequence alignment of Tcf1 and HDAC8 was based on comparison of the HDAC8 crystal structure and the modeled Tcf1 structure. Global alignment of conventional HDACs (excluding HDAC10) was performed with MUSCLE 52 . The 30-aa HDAC domain sequence in Tcf1 was also used to search homologous sequences in HDACs using the BLAST2 program. These approaches were combined to generate the multiple sequence alignments shown in Figure 7b .
Coevolution analysis of Tcf1 and Lef1 orthologs. Homologous sequences of Tcf1 and Lef1 were obtained from the UniProt database. If multiple sequences for each protein were obtained from one species, only one was retained for downstream analysis. Sequences that contained more than 50% gaps in (i) the global alignment or (ii) their corresponding regions that aligned to the Tcf1 HDAC domain were excluded from the analysis. The resulting 98 sequences from 56 species were used as input to DCA 30 for detection of coevolution of residue pairs.
